We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The new EU rules are “designed to improve product safety, ensuring greater openness, traceability and clinical safety evidence,” the company noted. Read More
Quebec, Canada-based OxyNov has filed a 510(k) submission to the FDA for its FreeO2 device that automatically adjusts a patient's oxygen flow. Read More